Disclosed are compounds which inhibit .beta.-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits .beta.-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

 
Web www.patentalert.com

< (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

< Methods for therapeutic use of glucosylceramide synthesis inhibitors and composition thereof

> Composition and treatment method for brain and spinal cord injuries

> Method and system for tracking small coils using magnetic resonance
~ 00098